WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Collplant Biotechnologies revenue was $515.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $164.0k, up 4,000% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLGN annual revenue was $515.0k, with -95.3% growth year-over-year.

CLGN past revenue growth

How has CLGN's revenue growth performed historically?

Company
-95.3%
Industry
497.69%
Market
20.68%
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLGN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLGN revenue history

Current Revenue
$515.0k
Current Earnings
-$16.6M
Current Profit Margin
-3,225%

Be the first to know when CLGN announces revenue.

CLGN Revenue History By Year

CLGN Yearly RevenueCLGN RevenueCLGN ChangeCLGN Revenue Growth
2024-12-31$515.00k-$10.44M-95.30%
2023-12-31$10.96M$10.66M+3,565.22%
2022-12-31$299.00k-$15.34M-98.09%
2021-12-31$15.64M$9.50M+154.86%
2020-12-31$6.14M$3.82M+164.75%
2019-12-31$2.32M-$2.70M-53.77%
2018-12-31$5.01M$4.55M+982.94%
2017-12-31$463.00k$381.82k+470.37%
2016-12-31$81.18kN/AN/A
2015-12-31$0.00N/AN/A

1 of 1

Collplant Biotechnologies Revenue FAQ

What was CLGN's revenue last quarter?

Collplant Biotechnologies (NASDAQ: CLGN) reported Q4 2024 revenue of $164.00 thousand up 45.15% year over year. In the same quarter last year, Collplant Biotechnologies's revenue was $299.00 thousand.

What was Collplant Biotechnologies's revenue in 2024?

Collplant Biotechnologies's annual revenue for the twelve months ending Dec 31, 2024 was $515.00 thousand, a 95.3% decrease year over year.

How much does Collplant Biotechnologies make in a day?

Based on Collplant Biotechnologies annual revenue for the past five years, CLGN makes an average of $18,384.11 per day.

What was Collplant Biotechnologies's annual revenue growth in the past year?

As of Q2 2025, Collplant Biotechnologies's revenue has grown -95.3% year over year. This is 592.99 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Collplant Biotechnologies's revenue in the past year totaled $515.00 thousand.

How much does Collplant Biotechnologies make in a year?

Collplant Biotechnologies's revenue by year for the past five years is:
  • Collplant Biotechnologies's revenue for the twelve months ending Dec 31, 2024 was $515.00 thousand, a 95.3% decrease year over year.
  • Collplant Biotechnologies's annual revenue for Dec 31, 2023 was $10.96 million, a 3,565.22% increase from 2022.
  • Collplant Biotechnologies's annual revenue for 2022 was $299.00 thousand, a 98.09% decrease from 2021.
  • Collplant Biotechnologies's annual revenue for 2021 was $15.64 million, a 154.86% increase from 2020.
  • Collplant Biotechnologies's annual revenue for 2020 was $6.14 million, a 164.75% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.